HOME
Highlights

Participants

Enterprise—— CEOs and R&D leaders Antibody Immunotherapy Development, Cellular Immunotherapy and Cell Products, Oncolytic Virus, Therapeutic Vaccine Scientific Research—— School Professor/Researcher Major in Life Science, Major in Pharmacy, Major in Medicine, Major in Immunology HCPs——Chief Physicians and Surgeons Hematology, Oncology, Biotherapy Upstream Providers Reagents and instruments Raw Materials, Scientific Research Services, Preclinical and Clinical CRO, Animal Model, Virus Vector, Gene Detection, Bioinformatics Services

Highlights

  • Regulation Registration and Technical Standard Analysis of Cell Therapy
  • Leading Experience in CMC, Processing and Manufacturing of Cellular Immunotherapeutic Products for Low Cost and High Efficiency
  • The Latest Technology and Development of Cellular Immunotherapy: Technological Advances in Immunotherapy including Neoantigen, TIL Cells, Macrophage, U-CAR etc
  • Proceeding from Tumor Microenvironment and Immunological Mechanism, Exploring the Innovative Development of Next-Gen Immunotherapy Drugs
  • Immunogene Combination Therapy -- Progress and Breakthroughs in Pharmaceutical and Pharmacodynamic Research of Oncolytic Virus Drugs and Therapeutic Cancer Vaccine
This event is technically supported by BagEvent
All rights reserved:Nanjing DIQi Information Technology Co., Ltd | Sue ICP No. 15059127 | Sue ICP license No. B2-20160175
Copyright©2023 bagevent.com